An industry for healthy lives

Europe is at the heart of global vaccine research and production. Most of the activities of the major innovative Vaccines Europe members research based-companies are based in the region.

News & press releases

European Immunisation Week. Prevent. Protect. Immunise

2013 03 13 Written by Vaccines Europe

This year’s European Immunisation Week (EIW) will take place from 22 to 27 April 2013. According to WHO European Region, more than 90,000 cases of measles were reported in the Region over the past three years, with more than half concerning adolescents or young adults. 80% of these were reported within EU Member States. Read more…

DG SANCO Report on Childhood Immunisation Conference

2013 03 12 Written by Vaccines Europe

European Commission publishes the summary report from the DG SANCO ‘Conference on Childhood Immunisation: progress, challenges and priorities for further action’ held in Luxembourg last year on 16-17 October 2012. In the light of recent measles outbreaks in the EU Member States and growing concerns around changing attitudes towards vaccines and vaccination, the conference aimed to take stock of EU initiatives undertaken as a follow-up to the Council conclusions on childhood immunisation adopted in June 2011.  Read more…

EDCTP and EFPIA sign memorandum of understanding on a Clinical Research Fellowship Scheme for sub-Saharan Africa

2013 01 24 Written by Nico

On the 24th of January a Memorandum of Understanding (MoU) for a fellowship scheme for clinical researchers was signed between the research-based drug companies in Europe (EFPIA) and the European & Developing Countries Clinical Trials Partnership (EDCTP). This innovative initiative will give sub-Saharan African researchers the possibility to be placed in a European-based pharmaceutical company for up to two years to develop skills in clinical trial research. Read more…

Interview with Andrea Rappagliosi, President of Vaccines Europe

2013 01 17 Written by Vaccines Europe

Andrea Rappagliosi

Q: You have just taken over as President of Vaccines Europe, the voice of Europe’s vaccines sector. What are the main challenges facing the industry in the years ahead?

A: The next main challenge for our Industry is to ensure that Europe retains excellence in prevention and immunisation programmes.  Lifespan immunisation is undoubtedly an essential  strategy  to achieve well-being and healthy ageing  both identified as critical success factors for the European Commission’s goal of smart, sustainable and inclusive growth in Europe by 2020. Read more…